SCHEMBL7449339

SCHEMBL7449339

CCCC(N)(N)CCC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
KMT2A Q03164 3/20 0.54
MEN1 O00255 2/20 0.54
CYP1A2 P05177 1/20 0.54
THRB P10828 1/20 0.54
FFAR3 O14843 1/20 0.48
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
AKR1B1 P15121 1/20 0.42
GPR84 Q9NQS5 7/20 0.41
PPARG P37231 7/20 0.41
PPARD Q03181 7/20 0.41
PPARA Q07869 7/20 0.41
HDAC11 Q96DB2 5/20 0.41
TSHR P16473 4/20 0.41
PTPN1 P18031 3/20 0.41
TLR2 O60603 2/20 0.41
TDP1 Q9NUW8 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27918817 0.87 KMT2A (0.52) ALDH1A1KMT2AMEN1CYP1A2THRB
SCHEMBL28136018 0.83 ALDH1A1 (0.61) ALDH1A1KMT2AMEN1CYP1A2THRB
SCHEMBL2147218 0.83 GPR84 (0.56) ALDH1A1KMT2AMEN1AKR1B1GPR84
SCHEMBL28738124 0.83 GPR84 (0.56) ALDH1A1KMT2AMEN1AKR1B1GPR84
SCHEMBL29132419 0.83 GPR84 (0.56) ALDH1A1KMT2AMEN1AKR1B1GPR84
SCHEMBL7385936 0.78 ALDH1A1 (0.40) ALDH1A1KMT2AMEN1CYP1A2THRB
SCHEMBL9005565 0.77 ALDH1A1 (0.73) ALDH1A1KMT2AMEN1CYP1A2THRB
SCHEMBL1399007 0.77 ALDH1A1 (0.73) ALDH1A1KMT2AMEN1CYP1A2THRB
SCHEMBL20692400 0.76 GABRP (0.45) ALDH1A1KMT2AMEN1CYP1A2THRB
SCHEMBL27801321 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1261611-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-12-04 EP disclosed
EP-1196436-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-04-17 EP disclosed
WO-2001064678-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-07 WO disclosed
WO-2001002424-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE DU PONT PHARMACEUTICALS COMPANY (US) 2001-01-11 WO disclosed